The University of Chicago Header Logo

Connection

John Hart to Biomarkers, Tumor

This is a "connection" page, showing publications John Hart has written about Biomarkers, Tumor.
Connection Strength

1.252
  1. Next-generation sequencing identifies 2 genomically distinct groups among pyloric gland adenomas. Hum Pathol. 2020 03; 97:103-111.
    View in: PubMed
    Score: 0.340
  2. Loss of microfibril-associated protein 5 (MFAP5) expression in colon cancer stroma. Virchows Arch. 2020 Mar; 476(3):383-390.
    View in: PubMed
    Score: 0.333
  3. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms. Am J Surg Pathol. 2010 Aug; 34(8):1147-54.
    View in: PubMed
    Score: 0.178
  4. Reduced MFAP5 expression in stroma of gallbladder adenocarcinoma and its potential diagnostic utility. Virchows Arch. 2021 Mar; 478(3):427-434.
    View in: PubMed
    Score: 0.090
  5. Recent developments in liver pathology. Arch Pathol Lab Med. 2009 Jul; 133(7):1078-86.
    View in: PubMed
    Score: 0.041
  6. Primary hepatic malignant fibrous histiocytoma: clinicopathologic characteristics and prognostic value of ezrin expression. Am J Surg Pathol. 2008 Aug; 32(8):1144-58.
    View in: PubMed
    Score: 0.039
  7. Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms. Am J Clin Pathol. 2005 Jul; 124(1):11-9.
    View in: PubMed
    Score: 0.031
  8. Immunohistochemical evaluation of adenomatous polyposis coli, beta-catenin, c-Myc, cyclin D1, p53, and retinoblastoma protein expression in syndromic and sporadic fundic gland polyps. Hum Pathol. 2004 Mar; 35(3):328-34.
    View in: PubMed
    Score: 0.029
  9. Caveolin and thrombospondin expression during hepatocellular carcinogenesis. Am J Surg Pathol. 2004 Mar; 28(3):357-64.
    View in: PubMed
    Score: 0.029
  10. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. Cancer Epidemiol Biomarkers Prev. 2002 Dec; 11(12):1653-62.
    View in: PubMed
    Score: 0.026
  11. Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up. Am J Gastroenterol. 2002 Jan; 97(1):27-31.
    View in: PubMed
    Score: 0.025
  12. Colorectal Carcinomas With Isolated Loss of PMS2 Staining by Immunohistochemistry. Arch Pathol Lab Med. 2018 Apr; 142(4):523-528.
    View in: PubMed
    Score: 0.019
  13. miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling. Inflamm Bowel Dis. 2017 08; 23(8):1328-1337.
    View in: PubMed
    Score: 0.018
  14. Interobserver variability in intraductal papillary mucinous neoplasm subtypes and application of their mucin immunoprofiles. Mod Pathol. 2016 09; 29(9):977-84.
    View in: PubMed
    Score: 0.017
  15. Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH. Gastric Cancer. 2016 Oct; 19(4):1066-1079.
    View in: PubMed
    Score: 0.016
  16. Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry. Mod Pathol. 2009 Aug; 22(8):1113-20.
    View in: PubMed
    Score: 0.010
  17. Basaloid squamous cell carcinoma of the esophagus with or without adenoid cystic features. Arch Pathol Lab Med. 2004 Oct; 128(10):1124-30.
    View in: PubMed
    Score: 0.007
  18. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol. 2001 Nov; 25(11):1380-7.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.